Randomised controlled trial to evaluate the efficacy of Vacha,Haridra,Sunthi Bidalaka in Klinna Vartma with reference to Squamous cell Blepharitis
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 64
- 试验地点
- 1
研究概览
简要总结
Untreated or ill managed disease leads to complication i.e. triachiasis, madarosis, corneal erosion,
marginal keratitis etc, so this should be treated as early as possible.
The modern line of treatment topical antibiotics and steroids ointment is available but due to longterm or improper use of drugs, drug resistance and steroids induced complications develops and
recurrence of disease occurs.So need to find the safe,easily available,cost effective, and definitive treatment to cure the
condition and to check the recurrence.
Vacha,Haridra,Shunthi Bidalaka consists of Vacha having Vednahara property.
Haridra having Shothahara, Vednasthapan, Kandughana, Vranashodhana and Vranaropana.
Shunthi having shoolaghna property.
Bidalaka is easy procedure and as it is locally used, it is fast acting procedures so that patient is
relieved fastly with his symptoms.
All dravyas are economical and easily available.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having signs and symptoms of Klinnavartma.
- •2.Patients in age group between 18 to 60 yrs will be selected irrespective of their sex, religion, socio-economic status.
- •3.Only those patients will be selected who are willing to give written consent.
排除标准
- •1.Patient having anyother known ocular pathology.
- •2.Any past or present history of ocular trauma.
- •3.Patients with k/c/o NLDBlock, Dacrocystitis, DM, HBsAg, HIV.
- •4.Patient having any contagious disease.
- •5.Patient recently under goes eye surgeries 6.One eyed patient.
研究者
Vd Sneha Sudhir Deshmukh
PMT Ayurved College and Shri Eknath Rugnalaya ,Shevgoan